MedTrace Logo

Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel in Patients With Acute Ankle Sprain

NCT00573768 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 271

Last updated 2012-04-20

Study results available
· View outcomes & findings →

Summary

This study will evaluate the efficacy of diclofenac diethylamine 2.32% gel in the treatment of acute ankle sprain.

Conditions

  • Ankle Sprain

Interventions

DRUG

Diclofenac diethylamine 2.32% gel

Diclofenac diethylamine 2.32% gel twice daily

DRUG

Placebo

Vehicle 2 times daily

DRUG

Diclofenac diethylamine 2.32% gel / Placebo

Diclofenac diethylamine 2.32% gel once daily / Vehicle once daily

Sponsors & Collaborators

Principal Investigators

  • Axel Baltzer

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2007-12-31
Completion
2008-07-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00573768 on ClinicalTrials.gov